A genomic and epigenomic atlas of prostate cancer in Asian populations

Journal: Nature

Published: 2020-03-25

DOI: 10.1038/s41586-020-2135-x

Affiliations: 29

Authors: 55

Go to article
Institutions Share
Changhai Hospital, SMMU, China 0.47
Washington University in St. Louis (WUSTL), United States of America (USA) 0.07
Shanghai Key Laboratory of Cell Engineering, China 0.06
Novogene Co., Ltd., China 0.04
First Affiliated Hospital, ZZU, China 0.04
Second Military Medical University (SMMU), China 0.02
Zhongda Hospital, SEU, China 0.02
Huadong Hospital Affiliated to Fudan University, China 0.02
Affiliated Hospital of Hebei University, HBU, China 0.02
Fujian Medical University, China 0.02
Shaoxing Central Hospital, China 0.02
LuoHu Affiliated Hospital of Shenzhen University, China 0.02
Zhejiang Provincial People's Hospital, China 0.02
Pudong Gongli Hospital, China 0.02
First Affiliated Hospital, AHMU, China 0.02
Xuzhou Central Hospital (XZCH), China 0.02
The First Affiliated Hospital of Soochow University, China 0.02
Daping Hospital, Army Medical University, China 0.02
First Affiliated Hospital, ZJU, China 0.02
Shanghai Changzheng Hospital, SMMU, China 0.02
Tongji Hospital (TJH), HUST, China 0.02
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China 0.01
Nanjing Medical University (NJMU), China 0.01
University of Chinese Academy of Sciences (UCAS), Shanghai, China 0.01
Shanghai Institute of Nutrition and Health (SINH), SIBS CAS, China 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER